R&D
Academician and Expert Workstation
In October 2015 Wepon Pharmaceutical Group reached a cooperation with Shanghai Institute of Materia Medica, Chinese Academy of Sciences and established the "Academician Expert Workstation"
The Academician and Expert Workstation is led by Tang Xican, an academician of the Chinese Academy of Engineering, doctoral supervisor, and researcher at the Shanghai Institute of Materia Medica, CAS. Together, they have assembled a high-level talent team and embarked on in-depth collaboration on the project involving huperzine A—a key raw material and formulation for anti-Alzheimer’s drugs—yielding remarkable achievements. To date, the project has secured a total of 10 international invention patents across China, the U.S., Japan, and the European Union.
In November 2018 it was rated as "National Model Academician and Expert Workstation"
In October 2023 Recognized as"Zhejiang Province's 'Second Batch of Provincial-Level Academician Workstations with Key Support'"
Academician Biography
Tang Xican
Member of the Chinese Academy of Engineering and Doctoral Supervisor
Researcher at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Editor-in-Chief of the Chinese Journal of New Drugs and Clinical Studies
Research Direction
Research and Development of Bioactive Natural Products Targeting Central Nervous System Disorders
50Remaining years
Engaging in the discovery of bioactive compounds from traditional Chinese medicine that target the nervous system, as well as research into their mechanisms of action.
200Remaining articles
To date, the research team he leads has published studies in renowned international and domestic academic journals.
68Article
Among them, research papers on the Huperzine A series have been published.
3Item
Domestic Invention Patent
4Item
International Patent
The project completed as the principal investigator has won a national-level award.7Item: Provincial and Ministerial-Level First-Class Science and Technology Award3Item, International Science and Technology Award1Item: Ho Leung Ho Lee Science and Technology Prize1Item and the China Pharmaceutical Development Award for Special Contribution1Item.
Main areas of collaboration at the workstation
Assist in advancing the collaborative enterprise's research on a series of products based on Huperzine A.
Comparative Study on the Pharmacological Effects of Synthetic Huperzine A vs. Natural Huperzine A
Pharmacological and Pharmacodynamic Study of Huperzine A Injection
Team members
Zhang Haiyan
Specializing in and researching drug target validation for central nervous system disorders and new drug development, I lead the overall design and provide guidance on pharmacological and efficacy studies within the academician team's projects.
Gong Qi
Responsible within the academician team for collaborating on clinical blood sample assays of acetylcholinesterase activity and biomarker measurements, as well as jointly conducting animal pharmacology studies related to the project.
Chen Jing
As the lead researcher for pharmacological and therapeutic studies on ischemic brain injury within the academician team, I am responsible for conducting relevant literature reviews, determining methodologies, and overseeing the practical implementation of these studies.
Zhang Jingjing
As the lead researcher for pharmacological and therapeutic studies on Alzheimer's disease within the academician team, I am responsible for conducting relevant literature reviews, designing study protocols, determining methodologies, and overseeing the execution of these initiatives.
Wang Wei
Responsible within the academician team for comparing the pharmacological effects of scopolamine and APP/PS1 transgenic animal behavior studies, as well as conducting related enzymatic assays.
Collaboration Content